Human glucose-6-phosphate isomerase,GPI ELISA Kit

Code CSB-E09589h
Size 96T,5×96T,10×96T
Price Request a Quote or Start an on-line Chat
Trial Size 24T ELISA Kit Trial Size (Only USD$150/ kit)
* The sample kit cost can be deducted from your subsequent orders of 96T full size kits of the same analyte at 1/5 per kit, until depleted in 6 months. Apply now

Product Details

Target Name
glucose phosphate isomerase
Alternative Names
AMF ELISA Kit; Aurocrine motility factor ELISA Kit; Autocrine motility factor ELISA Kit; DKFZp686C13233 ELISA Kit; EC 5.3.1.9 ELISA Kit; G6PI_HUMAN ELISA Kit; Glucose phosphate isomerase ELISA Kit; Glucose-6-phosphate isomerase ELISA Kit; GNPI ELISA Kit; GPI ELISA Kit; Gpi1 ELISA Kit; Hexose monophosphate isomerase ELISA Kit; Hexosephosphate isomerase ELISA Kit; Neuroleukin ELISA Kit; NLK ELISA Kit; Oxoisomerase ELISA Kit; PGI ELISA Kit; PHI ELISA Kit; Phosphoglucose isomerase ELISA Kit; Phosphohexomutase ELISA Kit; Phosphohexose isomerase ELISA Kit; Phosphosaccharomutase ELISA Kit; SA 36 ELISA Kit; SA-36 ELISA Kit; SA36 ELISA Kit; Sperm antigen 36 ELISA Kit
Abbreviation
GPI
Uniprot No.
Species
Homo sapiens (Human)
Sample Types
serum, plasma, tissue homogenates
Detection Range
12.5 ng/mL-800 ng/mL
Sensitivity
3.12 ng/mL
Assay Time
1-5h
Sample Volume
50-100ul
Detection Wavelength
450 nm
Research Area
Metabolism
Assay Principle
quantitative
Measurement
Sandwich
Precision
Intra-assay Precision (Precision within an assay): CV%<8%
Three samples of known concentration were tested twenty times on one plate to assess.
Inter-assay Precision (Precision between assays): CV%<10%
Three samples of known concentration were tested in twenty assays to assess.
Linearity
To assess the linearity of the assay, samples were spiked with high concentrations of human GPI in various matrices and diluted with the Sample Diluent to produce samples with values within the dynamic range of the assay.
SampleSerum(n=4)
1:1Average %91
Range %86-95
1:2Average %102
Range %97-107
1:4Average %91
Range %85-97
1:8Average %97
Range %91-103
Recovery
The recovery of human GPI spiked to levels throughout the range of the assay in various matrices was evaluated. Samples were diluted prior to assay as directed in the Sample Preparation section.
Sample TypeAverage % RecoveryRange
Serum (n=5) 9184-95
EDTA plasma (n=4)9790-102
Typical Data
These standard curves are provided for demonstration only. A standard curve should be generated for each set of samples assayed.
ng/mlOD1OD2AverageCorrected
8002.065 2.076 2.071 1.968
4001.580 1.557 1.569 1.466
2000.835 0.824 0.830 0.727
1000.432 0.445 0.439 0.336
500.285 0.278 0.282 0.179
250.190 0.198 0.194 0.091
12.50.139 0.133 0.136 0.033
00.102 0.104 0.103
Troubleshooting
and FAQs
Storage
Store at 2-8°C. Please refer to protocol.
Lead Time
3-5 working days after you place the order, and it takes another 3-5 days for delivery via DHL or FedEx
Description

This Human GPI ELISA Kit was designed for the quantitative measurement of Human GPI protein in serum, plasma, tissue homogenates. It is a Sandwich ELISA kit, its detection range is 12.5 ng/mL-800 ng/mL and the sensitivity is 3.12 ng/mL.

Customer Reviews and Q&A

 Customer Reviews

There are currently no reviews for this product.

Submit a Review here

Target Background

Function
(From Uniprot)
In the cytoplasm, catalyzes the conversion of glucose-6-phosphate to fructose-6-phosphate, the second step in glycolysis, and the reverse reaction during gluconeogenesis. Besides it's role as a glycolytic enzyme, also acts as a secreted cytokine: acts as an angiogenic factor (AMF) that stimulates endothelial cell motility. Acts as a neurotrophic factor, neuroleukin, for spinal and sensory neurons. It is secreted by lectin-stimulated T-cells and induces immunoglobulin secretion.
Gene References into Functions
  1. Study demonstrated a novel pathway regulating hypoxia-induced angiogenesis in rheumatoid arthritis mediated by glucose-6-phosphate isomerase. PMID: 28067317
  2. Our data suggest that glucose-6-phosphate isomerase gene polymorphism may serve as potential biomarkers to predict the overall survival of hepatocellular carcinoma. PMID: 27288297
  3. Mutation p.Gln413Arg fs*24 is the first frameshift null mutation to be described in GPI deficiency. Molecular modeling suggests that the structural change induced by the p.Gly87Ala pathogenic variant has direct impact in the structural arrangement of the region close to the active site of the enzyme. PMID: 27519939
  4. The 2 cysteines in hGPIc-c are prone to form disulfides upon oxidation. hGPIc-c could induce arthritis in both B10.Q and B10Q.Ncf1*/* mice, whereas hGPIs-s immunization did not induce disease at all, showing that these disulfides are critical for the arthritis-inducing immune response. The cysteines at position 330 and 333 are not crucial for TCR recognition. GILT expression affects hGPI-c-c processing at the CXXC motif. PMID: 29127146
  5. These results suggested that E4P by directly interacting with extracellular HPI/AMF may be an effective strategy to deter BCSC growth and progression. PMID: 28648642
  6. The silencing of PGI/AMF decreased the levels of phosphorylated Akt (-71.9%, P<0.001) compared with the scrambled siRNA, as well as the levels of the stemness marker, SOX2 (-61.7%, P<0.01). Taken together, these findings suggest that PGI/AMF silencing decreases migration, tumorsphere formation as well as the proportion of on the side population cells in glioblastoma U87 cells. PMID: 26936801
  7. NLK is able to promote cell proliferation and type II collagen synthesis during in vitro chondrocyte propagation. PMID: 26573126
  8. Suggest tha AMF/PGI-mediated tumorigenesis occurs through MAPK-ERK signaling in endometrial carcinoma. PMID: 26308071
  9. Study supports a role for AMF mediating epithelial-mesenchymal transition in endometrial cancer (EC) through MAPK signaling. Therefore, AMF may provide a potential prognostic and therapeutic target in preventing EC progression. PMID: 26201353
  10. Results showed an increase in GPI and AMFR in clear cell-renal cell carcinoma cells, and their colocalization on plasma membrane. Kaplan-Meier curves showed significant differences in survival among groups of patients with high versus low GPI. PMID: 26579829
  11. The association of ENO1 and GPI with postthaw sperm viability and motility was confirmed using Pearson's linear correlation. ENO1 and GPI can be used as markers of human sperm freezability before starting the cryopreservation procedure. PMID: 25910678
  12. High GPI expression is associated with metastatic phenotype of breast cancer. PMID: 24440856
  13. PGI is a moonlighting protein that functions as a cytosolic enzyme involved in glycolysis and gluconeogenesis, and as cytokine through binding to its cell surface receptor. PMID: 11004567
  14. Serum anti-GPI autoantibodies are useful for the diagnosis of rheumatoid arthritis in Chinese patients. PMID: 23773638
  15. Findings suggest that autocrine motility factor (AMF)-HER2 interaction might be a novel target for therapeutic management of patients with breast cancer, whose disease is resistant to trastuzumab. PMID: 23248119
  16. For PGI, an extended active site in which residues in the first, second, and third layers around the reacting substrate are predicted. PMID: 21970785
  17. GPI is a target gene of the BACH1 transcription factor according to ChIP-seq analysis in HEK 293 cells. PMID: 21555518
  18. By regulating ER calcium release, AMF/PGI interaction with gp78/AMFR therefore protects against ER stress identifying novel roles for these cancer-associated proteins in promoting tumor cell survival. PMID: 21252914
  19. Data suggest that elevated serum glucose-6-phosphate isomerase may be involved in the synovitis of rheumatoid arthritis and may prove useful as a serum marker for disease activity. PMID: 20810510
  20. Data show that effective downregulation of AMF/PGI expression and subsequent abrogation of AMF/PGI secretion, which resulted in morphologic change with reduced growth, motility, and invasion. PMID: 20978190
  21. autocrine motility factor/phosphoglucose isomerase against TGF-beta-induced apoptosis was correlated with its enzymatic activity PMID: 19819066
  22. hypoxia-induced gene in pancreatic cancer cell lines PMID: 11688991
  23. Overexpression induces neoplastic transformation and survival of NIH-3T3 fibroblasts. PMID: 12517804
  24. The results demonstrate that the enzymatic activity of PGI is not essential for either receptor binding or cytokine function of human PGI. PMID: 12527360
  25. crystal structure and analysis of the initial ring-opening step of catalysis PMID: 12573240
  26. role in regulating cell proliferation PMID: 12783864
  27. AMF regulates expression of Apaf-1 and caspase-9 genes via a complex signaling pathway and indirectly regulates formation of the apoptosome. (autocrine motility factor) PMID: 14566819
  28. The observations are consistent with a downstream mediation role of MMP-3 in Pohophoglucose isomerase/AMF-stimulated tumor cell metastasis. PMID: 14715248
  29. T-cell dependent peripheral polyarthritis induced by recombinant human glucose-6-phosphate isomerase in genetically unaltered mice demonstrates for the first time the induction of organ-specific disease by systemic autoimmunity. PMID: 15034067
  30. In addition to the findings in rheumatoid arthritis, our results indicate that GPI is not a general target of autoantibodies in juvenile idiopathic arthritis. PMID: 15290745
  31. Our results suggest that GPI variants may play a crucial role in the production of autoantibodies against ubiquitous GPI autoantigens. PMID: 15369782
  32. AMF expression significantly contributes to the aggressive phenotype of pancreatic cancer PMID: 15570012
  33. phosphoglucose isomerase/autocrine motility factor activities are differentially regulated by protein kinase CK2 phosphorylation PMID: 15637053
  34. interaction with hypoxia-inducible factor-1 drives mobility of erythroid progenitor cells PMID: 15850830
  35. N-glyco side-chain of AMFR is a trigger and that interaction between the 117-C-terminal part of AMF and the extracellular core protein of autocrine motility factor receptor (AMFR) is needed during AMF-AMFR interactions PMID: 16563432
  36. elevated G6PI levels present in patients with immune-based inflammatory arthritis may contribute to elevated levels of anti-G6PI Abs and G6PI/anti-G6PI immune complexes PMID: 16949042
  37. Missense mutations c.341A>T (p.Asp113Val) in exon 4 and c.663T>G (p.Asn220Lys) in exon 7 are associated with hereditary nonspherocytic hemolytic anemia. PMID: 17041899
  38. the receptor molecule for AMF/NLK/MF in leukemic differentiation is not gp78 PMID: 17071500
  39. raft-dependent endocytosis of AMF follows a distinct phosphatidylinositol 3-kinase-dependent pathway that is up-regulated in more aggressive tumor cells PMID: 17690101
  40. PGI/AMF is involved in oxidative stress-induced cellular senescence and should bring novel insights into the control of cellular growth leading to a new methodology for cancer treatment. PMID: 17925402
  41. IL-6 and Th17 play an essential role in GPI-induced arthritis PMID: 18311788
  42. Results of this study suggest that AMF stimulation stimulates MMP3 expression via a MAPK signaling pathway. PMID: 18485900
  43. Peptide fragment glucose phosphate isomerase (GPI)325-339 is identified as a major epitope in GPI-induced arthritis, with potential to induce polyarthritis. PMID: 18992137
  44. Mutations effect catalytic activity and structural stability of human glucose-6-phosphate isomerase. PMID: 19064002
  45. Expression of this protein leads to mesenchymal-topepithelial transition in breast cancer cells. PMID: 19531650
  46. overexpression of PGI significantly contributes to the aggressive phenotype of human colon cancer PMID: 19787266
  47. melanoma migration induced by AMF is mediated by autocrine production of IL-8 as a novel downstream modulator of the AMF signaling pathway PMID: 19801670

Show More

Hide All

Involvement in disease
Hemolytic anemia, non-spherocytic, due to glucose phosphate isomerase deficiency (HA-GPID)
Subcellular Location
Cytoplasm. Secreted.
Protein Families
GPI family
Database Links

HGNC: 4458

OMIM: 172400

KEGG: hsa:2821

UniGene: Hs.466471

CUSABIO guaranteed quality
icon of phone
Call us
301-363-4651 (Available 9 a.m. to 5 p.m. CST from Monday to Friday)
icon of address
Address
7505 Fannin St., Ste 610, Room 7 (CUBIO Innovation Center), Houston, TX 77054, USA
icon of social media
Join us with

Subscribe newsletter

Leave a message

* To protect against spam, please pass the CAPTCHA test below.
CAPTCHA verification
© 2007-2024 CUSABIO TECHNOLOGY LLC All rights reserved. 鄂ICP备15011166号-1